the commonest to form staghorn giant calculi
formed by urease producing bacteria
antibiotics have a role in the treatment
form at the two extremes of urinary pH range
D. form at the two extremes of urinary pH range
steinstrasse
a stone in ureterocele
fever, leucocytosis, pain
brushite stones
the surface area of the stones
the volume of the stones
the density of the stones
the number of the stones
orthophosphates may have a role in the treatment
hyperparathyroidectomy and levothyroxine replacement is the optimum treatment
management includes Calcium chelating agent and repeat 24hr urine collection in 3 months
surgical excision of the adenoma(s) is the treatment of choice
can be forgotten in place
vesico-renal reflux
calyceal perforation
detrusor irritability and/or hematuria
they are multiple and small in size
usually, they are voided spontaneously
they, rarely, form large stones within the peripheral zone
contrast CT is the conventional method for diagnosis
result from an inherited defect of renal tubular reabsorption of cysteine
characteristically, urate and cysteine stone are radiolucent
cysteine is a dibasic amino acid
on plain X-ray, cysteine stones exhibit ground-glass appearance
ESWL
PCNL with fulguration of the diverticulum
ureteroscopy with fulguration of the diverticulum
pyelolithotomy with diverticulectomy
stone chemical composition
stone burden
first stone vs. recurrent
stone density
renal insufficiency
active urinary tract infection
uncorrected bleeding disorder
third trimester pregnancy
dissolving homogenous nucleation
high tendency to form cystine sulfate stones
indicates the amount of dietary protein
post ESWL therapy
calcium monohydrate
calcium oxalate
ammonium urate
none of the above
it is characterized by low urinary magnesium and citrate
magnesium increases renal tubular citrate resorption
diarrheal is a remarkable side effect of magnesium therapy
potassium-magnesium preparations might restore urinary magnesium and citrate levels
Ca.oxalate monohydrate
cystine
matrix
Ca.oxalate dihydrate
≥ 2 cm diameter
upper calyx location
Na.urate composition
600 - 800 HU density
ESWL
PCNL
radial nephrolithotomy
pyelolithotomy with ureteral stenting
commonly unilateral
commonly due to repeated infections
urate stones are the second most common cause of staghorn calculi
ESWL monotherapy with ureteral stenting is the ideal treatment
formation of triple-phosphate stones
infection with Proteus species
increase production of endogenous uric acid
increase level of uric acid in THE blood
active UTI is an absolute contraindication
fluoroquinolone is the first choice for antimicrobial prophylaxis
withholding aspirin for only 10 days is enough
despite sterile urine, stone fragmentation might release hidden bacterial endotoxins and viable bacteria
by ensuring optimal coupling of the patient to the lithotripter
by running the treatment at a slower rate (60 shocks/min)
by running the treatment with general anesthesia
by all of the above
spinal cord injury
senile enlargement of prostate
augmented bladder
neurogenic hyper-reflexive bladder
upper, lower, mid
lower, upper, mid
mid, upper, lower
mid, lower, upper
2,8 dihydroxyadenine stones
sulfa medications-induced stones
calcium oxalate stones
matrix stones
when stones are multiple and/or recurrent
when stones form in childhood
in cases where nephrocalcinosis and urolithiasis are present
all of the above
watchful waiting
open surgical correction
IVU with possible endoscopic ureteral stenting
perc. nephrostomy tube insertion
chemical analysis of a recovered stone
hypercalcemia
CT finding
high breakability on ESWL
400 600 HU
600 800 HU
800 1000 HU
1000 1200 HU
blood cells more than pus cells
pus cells if infection was superadded
crystals might appear
all of the above
left ureterocele
bifid right renal pelvis
neurogenic bladder
bilateral UPJ stenosis
ciprofloxacin
indinavir
thiazides
triamterene
patients should be given large amounts of fluids to hasten stones passage
fluids are given to keep the patient well hydrated
the recommended regimen is 2 L of ringer lactate over 2 hours
fluids are contraindicated if desmopressin (DDAVP) was given